Northwestern Mutual Wealth Management’s Neumora Therapeutics NMRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$130K Hold
76,706
﹤0.01% 2167
2026
Q1
$150K Hold
76,706
﹤0.01% 2019
2025
Q4
$137K Hold
76,706
﹤0.01% 2012
2025
Q3
$140K Sell
76,706
-7
-0% -$11 ﹤0.01% 1934
2025
Q2
$56.3K Buy
76,713
+7
+0% +$5 ﹤0.01% 2207
2025
Q1
$76.7K Hold
76,706
﹤0.01% 2031
2024
Q4
$813K Buy
+76,706
New +$919K ﹤0.01% 1137

Other funds holding NMRA

Northwestern Mutual Wealth Management's NMRA Position: Q2 2026 in Review

Northwestern Mutual Wealth Management held its Neumora Therapeutics (NMRA) position steady in Q2 2026 at 76,706 shares worth $130K. The position accounts for ﹤0.01% of the portfolio, ranked #2167.

Northwestern Mutual Wealth Management first reported a position in NMRA in Q4 2024 and has held it in 7 quarters since. The position peaked at $813K in Q4 2024. 68 funds tracked by Wall St. Rank hold NMRA as of Q2 2026.

  • Northwestern Mutual Wealth Management held 76,706 shares of Neumora Therapeutics worth $130K as of Q2 2026.
  • Northwestern Mutual Wealth Management left its Neumora Therapeutics share count unchanged in Q2 2026.
  • Neumora Therapeutics made up ﹤0.01% of Northwestern Mutual Wealth Management's portfolio in Q2 2026, its #2167 holding.
  • Northwestern Mutual Wealth Management first reported a position in Neumora Therapeutics in Q4 2024 and has held it in 7 quarters since.
  • Northwestern Mutual Wealth Management's Neumora Therapeutics position peaked at $813K in Q4 2024.
  • 68 funds tracked by Wall St. Rank held Neumora Therapeutics as of Q2 2026.

Based on Northwestern Mutual Wealth Management's 13F filing for Q2 2026, filed 12 Aug 2026.